Trademark: 90009733
Status Date
Monday, July 24, 2023
Filing Date
Thursday, June 18, 2020
Published for Opposition
Tuesday, April 27, 2021
Abandoned Date
Monday, July 24, 2023
5 Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
Jul 24, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 24, 2023
Abandonment - No Use Statement Filed
Jun 30, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Jun 30, 2023
Teas Change Of Correspondence Received
Jun 30, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 30, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 13, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2022
Sou Extension 3 Granted
Dec 9, 2022
Sou Extension 3 Filed
Dec 9, 2022
Teas Extension Received
Jun 16, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 14, 2022
Sou Extension 2 Granted
Jun 14, 2022
Sou Extension 2 Filed
Jun 14, 2022
Teas Extension Received
Dec 15, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 13, 2021
Sou Extension 1 Granted
Dec 13, 2021
Sou Extension 1 Filed
Dec 13, 2021
Teas Extension Received
Jun 22, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 27, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 27, 2021
Published For Opposition
Apr 7, 2021
Notification Of Notice Of Publication E-Mailed
Mar 23, 2021
Approved For Pub - Principal Register
Mar 19, 2021
Teas/Email Correspondence Entered
Mar 19, 2021
Correspondence Received In Law Office
Mar 19, 2021
Teas Response To Office Action Received
Jan 12, 2021
Assigned To Examiner
Sep 21, 2020
Notification Of Non-Final Action E-Mailed
Sep 21, 2020
Non-Final Action E-Mailed
Sep 21, 2020
Non-Final Action Written
Sep 21, 2020
Assigned To Examiner
Jul 16, 2020
New Application Office Supplied Data Entered
Jun 22, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
